Clinical Trial Update: Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing aliskiren versus ramipril for antiproteinuric effects in hypertensive patients with type 2 diabetes and microalbuminuria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Aliskiren (Aliskiren)
• Ramipril (ramipril)

Snippet

Sponsor: University of Pavia | Conditions: Hypertension, Type 2 Diabetes | Phase 4 | Status: UNKNOWN